NCT03628638

Blood Sample Collection in Subjects Participating in a Lung Cancer Screening Program

2016-11: Blood Sample Collection in Subjects Participating in a Lung Cancer Screening Program

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 1,718 (actual)
• Sponsor: Exact Sciences Corporation · Industry
• Sex: All
• Age: 50 Years
• Healthy volunteers: Accepted

Summary

The primary objective of this study is to establish a control population to assess performance of an investigational diagnostic test targeting lung neoplasms.

Detailed description

Subjects will be participating in a lung cancer screening program at enrollment. Subjects will have a blood sample collected within 60 days of a low-dose CT scan (LDCT). Subjects with nodules present on the LDCT or subjects with a clean LDCT scheduled for a 12-month follow-up may have another blood draw at 12 months.

Conditions

• Healthy

Interventions

Type	Name	Description
OTHER	Blood Sample Collection	Subjects participating in the study will have blood sample collected at enrollment. . For any subjects scheduled for a 12 month follow-up, additional blood samples will be collected at 12 months from enrollment.

Timeline

• Start date: 2017-04-06
• Primary completion: 2021-01-31
• Completion: 2021-01-31
• First posted: 2018-08-14
• Last updated: 2021-02-15

Locations

31 sites across 1 country: United States